Searched for
VINITA GUPTA
More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...- Overweight Lupin, target price Rs 2,500: Axis SecuritiesAxis Securities gives an overweight call on Lupin with a target price of Rs 2500. The company reported a net profit of Rs 858.86 crore for ...
- Overweight on Lupin, target price Rs 2,600: Axis SecuritiesAxis Securities recommends an overweight call on Lupin with a target price of Rs 2600. Lupin's current price is Rs 2160. New launches in th...
- Just coming to our own in India; confident of growing our US business in next fiscal year: Lupin managementLupin's margin guidance remains around 19.5-20.5%. The company attributes its success to the pivot to complex products, cost-led initiative...
- What triggered Lupin’s growth spurt & can it be sustained?"From Q2 onwards, we expected to get back to double digit growth and are very happy that it is happening in Q1 itself. The growth year on y...
- Lupin appoints Spiro Gavaris as president of US generics bizSpiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...
- Lupin to resize portfolio, slash costs in US biz turnaroundIn an interview to ET, CEO Vinita Gupta said the company had already exited a few products filed from its Somerset facility in New Jersey a...
- Over 158 applications for generic products pending with USFDA for approval: LupinSharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last ...
- Buy Lupin, target Rs 815: Shrikant ChouhanBuy Lupin Ltd. at a price target of Rs 815.0 and a stop loss at Rs 775 from entry point.
- Buy Lupin, target Rs 880: Gaurav BissaBuy Lupin at a price target of Rs 880 and a stop loss at Rs 820 from entry point.
- Lupin founder DB Gupta, a self made maverick who wanted to take out TB in India, deadGupta is survived by wife and five children (four daughters and a son) Vinita Gupta, the eldest daughter and Nilesh Gupta were handed over ...
- Lupin looks to launch 25 products in US this fiscalIn the current year, apart from the Gavis portfolio, Fortamet and Glumetza, the company expects to launch products like Minastrin and Epzic...
- Lupin opens R&D facility to develop inhalation products in USDrug major Lupin today said it has opened a research and development centre for inhalation products in Florida, the US.
- Lupin looking to enter new product segments, geographies: MD Nilesh GuptaIn order to consolidate its business globally, the Mumbai-based firm has already inked various agreements in the previous fiscal.
- Debt-free Lupin is ready for big acquisition: Vinita Gupta, CEO"We are a debt-free company with cash in balance and can raise over a billion dollar-and-half," said CEO Vinita Gupta .
- Scouting for global acquisitions of brands, companies: LupinThe Mumbai-based firm is adopting a three-pronged approach in its acquisition strategy, which also includes the domestic market.
- Lupin Q4 net surges nearly three-fold to Rs 408 croreThe net profit of the drug major jumped to Rs 408 crore for the fourth quarter ended March 2013 against Rs 155 crore in the same period pre...
- Lupin to file new drug application for GSK’s $8 bn blockbuster inhaler AdvairMumbai-based drug maker Lupin Pharma will file an Abbreviated New Drug Application for GSK’s $8-billion dry powder inhaler Advair, said Vin...
- Vinita Gupta's entrepreneurial drive: Lupin now a big pharma player in the USLupin is now a big pharma player in the US both in generics and brands, thanks to Vinita Gupta's entrepreneurial drive.
- GeNext to prescribe new growth formula for LupinDesh Bandhu Gupta built Lupin into a $1-billion enterprise, but he will chart the journey to $3 billion and beyond with his two children.
Load More
